CoChat

The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.

Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

Open access
Ashton, Nicholas J., Ide, Mark, Zetterberg, Henrik, Blennow, Kaj · 2019 · Neurology and Therapy

Abstract

The search for accessible and cost-effective biomarkers to complement current cerebrospinal fluid (CSF) and imaging biomarkers in the accurate detection of Alzheimer disease (AD) and other common neurodegenerative disorders remains a challenging task. The advances in ultra-sensitive detection methods has highlighted blood biomarkers (e.g. amyloid-β and neurofilament light) as a valuable and realistic tool in a diagnostic or screening process. Saliva, however, is also a rich source of potential biomarkers for disease detection and offers several practical advantages over biofluids that are currently examined for neurodegenerative disorders. However, while this may be true for the general population, challenges in collecting saliva from an elderly population should be seriously considered. In this review, we begin by discussing how saliva is produced and how age-related conditions can modify saliva production and composition. We then focus on the data available which support the concept of salivary amyloid-β, tau species and novel biomarkers in detecting AD and alpha-synuclein (α-syn) in Parkinson's disease (PD).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s40120-019-00168-1

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 85 references

Cited by

See all 97

Metadata

Authors
Ashton, N. J., Ide, M., Zetterberg, H., & Blennow, K.
Affiliations
  • King's College London (GB)
  • Sahlgrenska University Hospital (SE)
Corresponding author
Ashton, Nicholas J.
Venue
Neurology and Therapy
Published
2019-12
Volume
8
Issue
S2
Pages
83-94
ISSN
  • 2193-6536 (ISSN-L)
  • 2193-8253
OpenAlex
W2989436137
Cited by
89
References
85
Citations by year
2026: 7 · 2025: 16 · 2024: 14 · 2023: 14 · 2022: 14 · 2021: 14 · 2020: 9 · 2019: 1
FWCI
1.12
Type
journal article
Language
en
Open access
Licence
Locations
  • Neurology and Therapy (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Wallenberg Centre for Molecular and Translational Medicine
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Physiology (medical) › Salivary Gland Disorders and Functions
Keywords
salivary biomarkers, Alzheimer's disease, neurodegenerative diseases, tau protein, alpha-synuclein, Parkinson's disease, saliva production, blood biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Salivary Biomarkers for Alzheimer’s Disease and Related Disorders. https://app.cochat.ai/papers/10.1007/s40120-019-00168-1
The paper
Ashton, N. J., Ide, M., Zetterberg, H., & Blennow, K. (2019). Salivary Biomarkers for Alzheimer’s Disease and Related Disorders. Neurology and Therapy. https://doi.org/10.1007/s40120-019-00168-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.